IRL757, potential 1st apathy treatment, begins Phase 1 testing
Dosing has begun in a Phase 1 clinical trial evaluating the safety and efficacy of IRL757, an oral…
Read Morebegins
Canada’s dental care plan begins today. Here’s what you need to know
The Canadian Dental Care Plan (CDCP) begins covering 1.9 million seniors today — but many patients may have…
Read More